Skip Navigation Links
Home
Products
Events
Resources
Support
Investors
Contact
Search Past Press
Investor News
Simulations Plus Releases Major Upgrade in ADMET Predictor 5.0
07/27/10
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, has released a major upgrade for its best-in-class ADMET Predictor™ software for predicting properties of molecules with only their structures as inputs.

Simulations Plus Reports Third Quarter FY2010 Financial Results
07/16/10
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP - News), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today reported financial results for its third quarter of fiscal year 2010 ended May 31, 2010 (3QFY10).

Simulations Plus Sets Date for 3rd Quarter Fiscal Year 2010 Earnings Release and Conference Call
07/15/10
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, announced that it expects to file its Form 10-Q quarterly report for the third quarter of its 2010 fiscal year ended May 31, 2010, with the Securities and Exchange Commission on Thursday, July 15, 2010. Chairman and CEO Walt Woltosz will host a conference call to discuss the Company’s performance on Friday, July 16, 2010, at 8:30 a.m. PT / 11:30 a.m. ET.

Simulations Plus Reports Preliminary Revenues for Third Fiscal Quarter of FY2010
06/21/10
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today released preliminary revenues for its third fiscal quarter ended May 31, 2010.

Simulations Plus Set to Rejoin Russell Microcap Index
06/16/10
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, will join the Russell Microcap® Index when Russell Investments reconstitutes its family of U.S. indexes on June 25, according to a preliminary list of additions posted June 11 on www.russell.com.

Simulations Plus Named “Company of the Month” by Investment Newsletter
05/27/10
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of software for pharmaceutical discovery and development, today announced that it has been named “Company of the Month” in the May issue of the investment newsletter The Bowser Report. Now in its 34th year, The Bowser Report is one of the oldest investment newsletters specializing in the analysis of low-priced, small-cap stocks.

SLP Subsidiary Words+ Launches EyePro™ System
05/10/10
LANCASTER, Calif.--(BUSINESS WIRE)-- Words+, Inc., a leading provider of augmentative communication and assistive technology hardware and software for people with disabilities, announced today that it has launched EyePro™, a new product that allows a person to operate an augmentative communication system or computer by simply looking at the screen. Words+ is a wholly owned subsidiary of Simulations Plus, Inc. (NASDAQ: SLP).

Simulations Plus Reports Second Quarter FY2010 Financial Results
04/15/10
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today reported financial results for its second quarter of fiscal year 2010 ended February 28, 2010 (2QFY10).

Simulations Plus Sets Date for 2nd Quarter Fiscal Year 2010 Earnings Release and Conference Call
04/13/10
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ:SLP - News), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, announced that it expects to file its Form 10-Q quarterly report with the Securities and Exchange Commission on Wednesday, April 14, 2010, for the second quarter of its 2010 fiscal year ended February 28, 2010. Chairman and CEO Walt Woltosz will host a conference call and webinar to discuss the Company’s performance on Thursday, April 15, 2010, at 9:00 AM PDT / 12:00 noon EDT.

Simulations Plus Reports Preliminary Revenues for Second Fiscal Quarter of FY2010, Files Amendment to Form 10K for FY2009
03/04/10
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of software for pharmaceutical discovery and development, today released preliminary revenues for its second fiscal quarter ended February 28, 2010, and announced that it has filed an amendment to its Annual Report on Form 10K for its fiscal year 2009 with the Securities and Exchange Commission (SEC) in response to comments by the SEC regarding that report.